Literature DB >> 28159605

Incidence, Frequency, and Clinical Characteristics of Type 3 Myocardial Infarction in Clinical Practice.

Nikolaj Jangaard1, Laura Sarkisian1, Lotte Saaby1, Søren Mikkelsen2, Anne Marie Lassen3, Niels Marcussen4, Jørgen L Thomsen5, Axel C P Diederichsen1, Kristian Thygesen6, Hans Mickley7.   

Abstract

OBJECTIVES: Cardiac death in a patient with symptoms and electrocardiographic changes indicative of myocardial ischemia but without available measurements of cardiac biomarkers is designated a type 3 myocardial infarction. We wanted to investigate the incidence, the frequency, and the characteristics of patients diagnosed as type 3 myocardial infarction.
METHODS: The occurrence of deaths in a well-defined geographic region was retrieved from the Danish Civil Registration System during a 1-year period from 2010 to 2011. Complementary data concerning causes of deaths were obtained from the Danish Register of Causes of Death, and ambulance and hospital patient files. Adjudication of the diagnosis was done by 2 local experts and one external senior cardiologist.
RESULTS: A total of 2766 of the 246,723 adult residents in the region had died. A type 3 myocardial infarction was diagnosed in 18 individuals, corresponding to an annual incidence of 7.3/100,000 person-years. During the same 1-year period, 488 patients had other types of myocardial infarction implying a 3.6% frequency of type 3 myocardial infarction (18 of 506) among all myocardial infarctions.
CONCLUSION: Type 3 myocardial infarction is a rare observation in clinical practice with an annual incidence below 10/100,000 person-years and a frequency of 3%-4% among all types of myocardial infarction. If autopsy data are included, the number of type 3 myocardial infarctions will increase.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mortality/survival; Quality and outcomes; Resource utilization; Syncope

Mesh:

Substances:

Year:  2017        PMID: 28159605     DOI: 10.1016/j.amjmed.2016.12.034

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  2 in total

1.  Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists.

Authors:  Cristina Rebordosa; Estel Plana; Annalisa Rubino; Jaume Aguado; David Martinez; Alejhandra Lei; Sami Daoud; Nuria Saigi-Morgui; Susana Perez-Gutthann; Elena Rivero-Ferrer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-08-02

Review 2.  Diagnosis of myocardial infarction at autopsy: AECVP reappraisal in the light of the current clinical classification.

Authors:  Katarzyna Michaud; Cristina Basso; Giulia d'Amati; Carla Giordano; Ivana Kholová; Stephen D Preston; Stefania Rizzo; Sara Sabatasso; Mary N Sheppard; Aryan Vink; Allard C van der Wal
Journal:  Virchows Arch       Date:  2019-09-14       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.